Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 9—September 2004
Research

Viral Loads in Clinical Specimens and SARS Manifestations

I.F.N. Hung*, V.C.C. Cheng*, A.K.L. Wu†, B.S.F. Tang*, K.H. Chan*, C.M. Chu‡, M.M.L. Wong§, W.T. Hui*, L.L.M. Poon*, D.M.W. Tse§, K.S. Chan‡, P.C.Y. Woo*, S.K.P. Lau*, J.S.M. Peiris*, and K.Y. Yuen*Comments to Author 
Author affiliations: *Queen Mary Hospital at the University of Hong Kong, Hong Kong Special Administrative Region (SAR), People’s Republic of China; †Prince of Wales Hospital, Hong Kong SAR, People’s Republic of China; ‡United Christian Hospital, Hong Kong SAR, People’s Republic of China; §Caritas Medical Centre, Hong Kong SAR, People’s Republic of China

Main Article

Table 2

SARS-CoV and viral load in different clinical specimens taken during days 10 to 15 after the onset of symptomsa

Clinical specimens Mean viral load in log10 copies/mL (SD), all specimens Mean viral load in log10 copies/mL (SD), positive specimens only Positivity by RT-qPCR (%)
NPA (n = 142) 2.4 (3.1) 5.8 (1.7) 60/142 (42.3)
Serum (n = 53) 1.1 (1.4) 2.7 (0.6) 22/53 (41.5)
Stool (n = 94) 6.1 (3.0) 7.0 (2.1) 82/94 (87.2)
Urine (n = 111) 1.3 (2.1) 4.4 (1.3) 32/111 (28.8)

aSARS-CoV, severe acute respiratory syndrome–associated coronavirus; SD, standard deviation; RT-qPCR, quantitative reverse transcription–polymerase chain reaction; NPA, nasopharyngeal aspirates.

Main Article

Page created: March 29, 2011
Page updated: March 29, 2011
Page reviewed: March 29, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external